FdaApplication
NDA 012026
Identifiers
- fda_app_no: NDA012026
Properties
| Property | Value |
|---|---|
| applicant_name | NOVARTIS PHARMACEUTICALS CORP |
| application_type | NDA |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| APRESOLINE-ESIDRIX | HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE | 25MG;15MG | TABLET;ORAL |
1 product